Ex Parte Petersen - Page 37


             Appeal No. 2006-0704                                                            Page 37                
             Application No. 10/060,697                                                                             

             Therefore, as I understand O’Leary, when the solution is such that the demineralized                   
             bone cannot be properly sequestered for a particular surgical application, a thickening                
             agent (or protein-sequestering agent) should be included in the composition.  One such                 
             thickening agent, or protein-sequestering agent, taught by O’Leary is hydroxypropyl                    
             methylcellulose.  Apparently recognizing the same problem with their composition, Yim                  
             teaches the use of hydroxypropyl methylcellulose, as well as calcium sulfate, as a                     
             protein-sequestering agent.  Yim, column 7, lines 26-37, 50-54 and column 8, lines 25-                 
             30.  Based on the foregoing analysis, it would appear that the combination of O’Leary                  
             and Yim, would overcome the disadvantage Wironen attributes to the O’Leary                             
             composition.  Accordingly, I am not persuaded by appellants’ argument.                                 
                    On reflection, it is my opinion that the evidence of record supports the examiner’s             
             conclusion that a bone repair composition comprising calcium sulfate; demineralized                    
             bone matrix; cancellous bone; hydroxypropyl methylcellulose; and a mixing solution                     
             would have been prima facie obvious to a person of ordinary skill in the art at the time               
             the invention was made.  As discussed above, appellants’ arguments to the contrary are                 
             insufficient to rebut this prima facie case of obviousness.  Accordingly, I would affirm the           
             rejection of claim 16 under 35 U.S.C. § 103 as being unpatentable over the combination                 
             of O’Leary, Yim and Wironen.  As discussed above, claims 17-22 fall together with                      
             claim 16.                                                                                              


                                                     Claim 23                                                       
                    As discussed above, claim 23 depends from and further limits the composition of                 
             claim 16 to require specified concentrations of ingredients.  Appellants provide no                    





Page:  Previous  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  Next 

Last modified: November 3, 2007